The 2012 US Cancer Diagnostics Market


March 28, 2012
620 Pages - SKU: VPG3815841
License type:
Table of Contents Related Reports
Countries covered: United States

This report presents a comprehensive analysis of the US cancer diagnostics market, including:

 

  • Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals, commercial laboratories, physician offices and cancer clinics.
  • Placements and installed base of automated and semiautomated analyzers used for cancer testing.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.



More Oncology/Hematology reports by Venture Planning Group

2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers by Venture Planning Group
This new 366-page report from Venture Planning Group contains 39 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, ...
Competing in the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK by Venture Planning Group
This new 820-page five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five ...
Competing in the US Cancer Diagnostics Market by Venture Planning Group
HighlightsThis new 620-page study of the US cancer diagnostics market from Venture Planning Group provides:Major issues pertaining to the US laboratory practice, as well as ...
Competing in the Global Cancer Diagnostics Market by Venture Planning Group
This new Venture Planning Group comprehensive seven-countrystudy identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the nextfive years; examines trends ...
See all reports like this >>

More United States Oncology/Hematology reports

2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers by Venture Planning Group
This new 366-page report from Venture Planning Group contains 39 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, ...
MediPoint: Predictive Breast Cancer Gene Testing - US Analysis and Market Forecasts by GlobalData
MediPoint: Predictive Breast Cancer Gene Testing - US Analysis and Market ForecastsSummaryBreast cancer is the most common form of cancer in women in both the ...
Competing in the US Cancer Diagnostics Market by Venture Planning Group
HighlightsThis new 620-page study of the US cancer diagnostics market from Venture Planning Group provides:Major issues pertaining to the US laboratory practice, as well as ...
The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for cancer therapy pharmaceuticals across the states and cities of the United States. Latent demand (in millions ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Oncology/Hematology Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!